Prognosis

South Africa in ‘Advanced Stage’ Talks With J&J About Vaccines

A medical worker administers an injection to a volunteer during a phase 3 trial of the Johnson & Johnson Covid-19 vaccine in Barcelona, Spain, on Dec. 17, 2020. — A medical worker administers an injection to a volunteer during a phase 3 trial of the Johnson & Johnson Covid-19 vaccine in Barcelona, Spain, on Dec. 17, 2020.
Photographer: Angel Garcia/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By John Bowker

January 7, 2021 at 4:53 PM UTC

This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

South Africa is in advanced talks with Johnson & Johnson about a deal to receive the U.S. drugmaker’s coronavirus vaccine candidate, part of a wider effort to inoculate two-thirds of the population by the end of the year.